Neoadjuvant therapy for melanoma: new and evolving concepts

Area of Science:

• Oncology
• Dermatology
• Immunology

Background:

• Malignant melanoma treatment has been revolutionized by systemic therapies.
• Neoadjuvant therapy is emerging as a promising approach for node-positive and oligometastatic melanoma.

Purpose of the Study:

• To review the current landscape of neoadjuvant therapy for melanoma.
• To summarize completed and ongoing clinical trials.
• To discuss future directions in neoadjuvant melanoma treatment.

Main Methods:

• Literature review of neoadjuvant clinical trials in melanoma.
• Analysis of targeted BRAF/MEK inhibition and immune checkpoint blockade efficacy.
• Synthesis of findings within the context of current melanoma treatment paradigms.

Main Results:

• Neoadjuvant therapy demonstrates promising clinical trial findings for specific melanoma patient groups.
• Targeted therapies and immune checkpoint inhibitors are key components of neoadjuvant regimens.
• The review contextualizes neoadjuvant treatment within advances in systemic therapy.

Conclusions:

• Neoadjuvant therapy represents a significant shift in melanoma management, particularly for advanced disease.
• Future research should focus on biomarker development and novel therapeutic combinations.
• Evolving surgical indications are crucial for integrating neoadjuvant approaches.